Xtx Topco LTD Intellia Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 14,902 shares of NTLA stock, worth $170,031. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,902
Previous 50,464
70.47%
Holding current value
$170,031
Previous $1.13 Million
72.9%
% of portfolio
0.02%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$140 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$110 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$58.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$56.5 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $867M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...